Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study
R Brauer, B Alfageh, JE Blais, EW Chan… - The Lancet …, 2021 - thelancet.com
Summary Background The WHO Comprehensive Mental Health Action Plan 2013–2030
encourages routine collection and reporting of a set of essential mental health indicators …
encourages routine collection and reporting of a set of essential mental health indicators …
Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and …
Background and aims: New therapeutic options such as lisdexamfetamine and guanfacine
have recently become available for the treatment of attention deficit hyperactivity disorder …
have recently become available for the treatment of attention deficit hyperactivity disorder …
Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study
Background Psychotropic polypharmacy and high-dose prescribing may play a role in
therapy, however, with associated risks. The aim of this study was to describe current …
therapy, however, with associated risks. The aim of this study was to describe current …
Generating real-world evidence on the quality use, benefits and safety of medicines in Australia: history, challenges and a roadmap for the future
SA Pearson, N Pratt, J de Oliveira Costa… - International journal of …, 2021 - mdpi.com
Australia spends more than $20 billion annually on medicines, delivering significant health
benefits for the population. However, inappropriate prescribing and medicine use also result …
benefits for the population. However, inappropriate prescribing and medicine use also result …
Trends in utilization and dosing of antipsychotic drugs in Scandinavia: comparison of 2006 and 2016
Aims The aim of this study was to investigate time trends in dosing and prevalence of
antipsychotic prescriptions in Scandinavia. Methods We retrieved data on antipsychotic use …
antipsychotic prescriptions in Scandinavia. Methods We retrieved data on antipsychotic use …
A national study on prescribed medicine use in Australia on a typical day
Abstract Purpose To describe Australians' prescribed medicine use on a typical day
(September 25, 2018). Methods We conducted a cross‐sectional study using nationally …
(September 25, 2018). Methods We conducted a cross‐sectional study using nationally …
The relative lethal toxicity of pharmaceutical and illicit substances: A 16‐year study of the Greater Newcastle Hunter Area, Australia
J Brett, CE Wylie, J Raubenheimer… - British journal of …, 2019 - Wiley Online Library
Aims We aim to calculate 2 metrics of relative lethal toxicity; the fatal toxicity index (FTI;
number of deaths per year of a daily dose) and the case fatality (CF; number of deaths per …
number of deaths per year of a daily dose) and the case fatality (CF; number of deaths per …
Development of prescribing safety indicators related to mental health disorders and medications: Modified e‐Delphi study
WY Khawagi, DT Steinke, J Nguyen… - British Journal of …, 2021 - Wiley Online Library
Aim To develop a set of prescribing safety indicators related to mental health disorders and
medications, and to estimate the risk of harm associated with each indicator. Method A …
medications, and to estimate the risk of harm associated with each indicator. Method A …
A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy
Aims To examine prescribed psychotropic medicine use on a given day in Australia (25
September 2018; World Pharmacists Day), with a focus on psychotropic polypharmacy …
September 2018; World Pharmacists Day), with a focus on psychotropic polypharmacy …
Changes in prescription of psychotropic drugs after introduction of polypharmacy reduction policy in Japan based on a large-scale claims database
Y Hirano, Y Ii - Clinical Drug Investigation, 2019 - Springer
Abstract Background and Objectives In Japan, polypharmacy reduction policy, which
reduces the reimbursement of medical cost, was introduced to address unnecessary …
reduces the reimbursement of medical cost, was introduced to address unnecessary …